SMPD3 and breast carcinoma: Neutral sphingomyelinase 2 (nSMase2) could promote breast cancer cells to secrete exosomes loaded with miR-210, to enhance the angiogenic activity of endothelial cells, thereby increasing lung metastasis of breast cancer [55].